1. Pandemic influenza A (H1N1) in HIV-1-infected patients
- Author
-
Cristina Moreno, Ricardo Rabagliati, María Elena Ceballos, Maria I Dominguez, Martin Lasso, Patricia Vásquez, Carlos M. Pérez, Jaime Labarca, and Michel Serri
- Subjects
Adult ,Male ,medicine.medical_specialty ,Immunology ,Population ,HIV Infections ,medicine.disease_cause ,Influenza A Virus, H1N1 Subtype ,Acquired immunodeficiency syndrome (AIDS) ,Antiretroviral Therapy, Highly Active ,Internal medicine ,Influenza, Human ,Pandemic ,Influenza A virus ,medicine ,Humans ,Immunology and Allergy ,Prospective Studies ,Chile ,education ,Pandemics ,Aged ,education.field_of_study ,business.industry ,virus diseases ,Middle Aged ,Viral Load ,medicine.disease ,Pneumonia ,Infectious Diseases ,Viral disease ,medicine.symptom ,business ,Odynophagia ,Viral load - Abstract
Objective To characterize the clinical presentation, course and mortality of pandemic influenza in HIV-1-infected patients in Santiago, Chile. Methods Prospective observational study. Results Thirty patients were included (three hospitalized), 93% were on HAART, mean CD4(+) cell count was 423 cells/μl and viral load was undetectable in 77% of patients. All patients had fever, 90% had cough, 80% had myalgias, 70% had pharyngeal congestion, 47% had coryza, 47% had odynophagia, 37% had headache and 23% had vomiting. Four patients developed pneumonia. All patients received antiviral therapy and no patient died. Conclusions HIV patients infected by the new influenza A pandemic (H1N1) virus behave similarly to the general population.
- Published
- 2010
- Full Text
- View/download PDF